aacr 2009: genetic influences in response to egfr for metastatic colorectal cancer
Published 14 years ago • 766 plays • Length 4:16Download video MP4
Download video MP3
Similar videos
-
4:03
aacr 2009: selecting appropriate first line lung cancer therapy
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
7:42
egfr-targeted therapy in metastatic colorectal cancer
-
5:19
targeting braf v600e in metastatic colorectal cancer: where are we today?
-
4:27
chronos trial: anti-egfr rechallenge therapy with panitumumab driven by ctdna molecular selectio...
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
6:32
panitumumab triplet therapy in colorectal cancer
-
17:17
debate: targeted therapy for ras/braf wt left sided colon cancers - egfr antibodies are mandatory
-
4:15
egfr in metastatic colon cancer
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
7:36
emccc 2010: the use of panitumumab to treat colorectal cancer
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
1:44
europacolon survey of the unmet needs of metastatic colorectal cancer patients
-
1:39
dr. kopetz on the significance of tumor sidedness in crc
-
2:02
stage 4 colorectal cancer thriver is running for research
-
5:36
pathways of resistance in metastatic colorectal cancer
-
24:33
molecular markers beyond kras for anti-egfr targeted agents — what is new?